COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:CBHD • DK0060448595

66.78 EUR
-5.5 (-7.61%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CBHD. CBHD was compared to 68 industry peers in the Health Care Equipment & Supplies industry. While CBHD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively. Finally CBHD also has an excellent dividend rating. With these ratings, CBHD could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CBHD was profitable.
  • CBHD had a positive operating cash flow in the past year.
  • CBHD had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CBHD had a positive operating cash flow.
CBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFCBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • CBHD has a Return On Assets of 7.52%. This is amongst the best in the industry. CBHD outperforms 83.82% of its industry peers.
  • Looking at the Return On Equity, with a value of 22.55%, CBHD belongs to the top of the industry, outperforming 91.18% of the companies in the same industry.
  • CBHD's Return On Invested Capital of 12.65% is amongst the best of the industry. CBHD outperforms 89.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CBHD is above the industry average of 9.62%.
Industry RankSector Rank
ROA 7.52%
ROE 22.55%
ROIC 12.65%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
CBHD.DE Yearly ROA, ROE, ROICCBHD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.04%, CBHD is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
  • CBHD's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 27.52%, CBHD belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
  • CBHD's Operating Margin has declined in the last couple of years.
  • CBHD's Gross Margin of 67.97% is fine compared to the rest of the industry. CBHD outperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
Industry RankSector Rank
OM 27.52%
PM (TTM) 13.04%
GM 67.97%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
CBHD.DE Yearly Profit, Operating, Gross MarginsCBHD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CBHD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, CBHD has about the same amount of shares outstanding.
  • The number of shares outstanding for CBHD has been increased compared to 5 years ago.
  • The debt/assets ratio for CBHD has been reduced compared to a year ago.
CBHD.DE Yearly Shares OutstandingCBHD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CBHD.DE Yearly Total Debt VS Total AssetsCBHD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.82 indicates that CBHD is not in any danger for bankruptcy at the moment.
  • CBHD has a Altman-Z score of 3.82. This is in the better half of the industry: CBHD outperforms 69.12% of its industry peers.
  • The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
  • CBHD has a Debt to FCF ratio (4.34) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.24 is on the high side and indicates that CBHD has dependencies on debt financing.
  • CBHD's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CBHD is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 4.34
Altman-Z 3.82
ROIC/WACC2.11
WACC5.98%
CBHD.DE Yearly LT Debt VS Equity VS FCFCBHD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • CBHD has a Current Ratio of 1.61. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.61, CBHD perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.00, CBHD perfoms like the industry average, outperforming 42.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1
CBHD.DE Yearly Current Assets VS Current LiabilitesCBHD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CBHD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.93%.
  • Measured over the past years, CBHD shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.02% on average per year.
  • CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
  • The Revenue has been growing by 8.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.23% on average over the next years. This is quite good.
  • Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 6.95% on average per year.
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y16.23%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CBHD.DE Yearly Revenue VS EstimatesCBHD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
CBHD.DE Yearly EPS VS EstimatesCBHD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.06, the valuation of CBHD can be described as expensive.
  • CBHD's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.92. CBHD is around the same levels.
  • The Price/Forward Earnings ratio is 19.11, which indicates a rather expensive current valuation of CBHD.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
  • CBHD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.06
Fwd PE 19.11
CBHD.DE Price Earnings VS Forward Price EarningsCBHD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CBHD's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than 72.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.09
EV/EBITDA 14.81
CBHD.DE Per share dataCBHD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CBHD has a very decent profitability rating, which may justify a higher PE ratio.
  • CBHD's earnings are expected to grow with 21.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)N/A
EPS Next 2Y27.22%
EPS Next 3Y21.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.28%, CBHD is a good candidate for dividend investing.
  • CBHD's Dividend Yield is rather good when compared to the industry average which is at 1.03. CBHD pays more dividend than 97.06% of the companies in the same industry.
  • CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

  • The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
CBHD.DE Yearly Dividends per shareCBHD.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

5.3 Sustainability

  • CBHD pays out 136.36% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
CBHD.DE Yearly Income VS Free CF VS DividendCBHD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
CBHD.DE Dividend Payout.CBHD.DE Dividend Payout, showing the Payout Ratio.CBHD.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COLOPLAST-B

FRA:CBHD (2/6/2026, 7:00:00 PM)

66.78

-5.5 (-7.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06
Earnings (Next)05-12
Inst Owners28.86%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap14.04B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70.4
Price Target88.27 (32.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.72%
PT rev (3m)-1.61%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)13.44%
EPS NY rev (1m)0.08%
EPS NY rev (3m)-0.23%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)9.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 28.06
Fwd PE 19.11
P/S 3.76
P/FCF 20.09
P/OCF 15.77
P/B 6.5
P/tB N/A
EV/EBITDA 14.81
EPS(TTM)2.38
EY3.56%
EPS(NY)3.49
Fwd EY5.23%
FCF(TTM)3.32
FCFY4.98%
OCF(TTM)4.23
OCFY6.34%
SpS17.76
BVpS10.27
TBVpS-8.72
PEG (NY)0.6
PEG (5Y)N/A
Graham Number23.45
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 22.55%
ROCE 18.32%
ROIC 12.65%
ROICexc 12.94%
ROICexgc 47.68%
OM 27.52%
PM (TTM) 13.04%
GM 67.97%
FCFM 18.72%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 4.34
Debt/EBITDA 2.2
Cap/Depr 98.21%
Cap/Sales 5.12%
Interest Coverage 9.3
Cash Conversion 72.84%
Profit Quality 143.51%
Current Ratio 1.61
Quick Ratio 1
Altman-Z 3.82
F-Score6
WACC5.98%
ROIC/WACC2.11
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y16.23%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.49%
EBIT Next 3Y14.67%
EBIT Next 5Y11.91%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%

COLOPLAST-B / CBHD.DE FAQ

What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.


Can you provide the valuation status for COLOPLAST-B?

ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for COLOPLAST-B?

COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.


How financially healthy is COLOPLAST-B?

The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.


What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?

The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.9% in the next year.